Introduction:Contraceptive implants are one of the most effective
methods of birth spacing. Jadelle® implants
consist of two strands that are easy to insert and remove. Although their
effectiveness is no longer in question, their use (insertion) requires a
surgical procedure with the corollary possibility of complications. These are
mainly insertions that are too deep (in the arm muscle), vascular and nerve
damage. Material and Methods: Our study focused on complications related
to implant insertion. It was a descriptive and retrospective study over
thirty-four months, from October 2016 to July 2019, and concerned all patients
seen in consultation and who presented a complication related to the insertion
of contraceptive implants in the Department of Gynecology and Obstetrics of the
National Hospital of Pikine. Results: We collected nine complications
managed at the Gynecology and Obstetrics Department of the Centre Hospitalier
National de Pikine from 2016 to 2019. These were insertions that were too deep
with sometimes nerve damage, infection or incident during anesthesia. The
operative procedures were based on the type of complication. Conclusion: Although
Jadelle® has the advantage of having only 2 rods compared to its predecessor
Norplant®, its use is also conditioned by insertion and removal procedures which
may experience complications.
References
[1]
Organisation Mondiale de la Santé (OMS) (2010) Recevabilité médicale de l’utilisation des contraceptifs. 4ème édition, OMS, Genève.
[2]
Singh, K., Viegas, O. and Loke, D. (1992) Effect of Norplant®-2 Rods on Liver, Lipid and Carbohydrate Metabolism. Contraception, 45, 463-472.
https://doi.org/10.1016/0010-7824(92)90159-Q
[3]
Colau, J. (2002) Contraception implantable Historique Extrait des mises à jour en Gynécologie et Obstétrique Tome XXVI.
[4]
Alvarez-Sanchez, F., Brache, V. and Faundes, A. (1988) The Clinical Performance of NORPLANT@R Implants over Time: A Comparison of Two Cohorts. Studies in Family Planning, 19, 118-121. https://doi.org/10.2307/1966496
[5]
Sivin, I., Lähteenmäki, P., Mishell Jr., D.R., Alvarez, F., Diaz, S., Ranta, S., Grozinger, C., Lacarra, M., Brache, V., Pavez, M., Nash, H. and Stern, J. (1997) First Week Drug Concentrations in Women with Levonorgestrel Rod or Norplant Capsule Implants. Contraception, 56, 317-321.
https://doi.org/10.1016/S0010-7824(97)00153-4
[6]
The Population Council (1990) Norplant® Subdermal Contraceptive Implants: Manual for HW. The Population Council, New York.
[7]
Siswosudarmo, R. (1992) Insertion de Norplant avec et sans antibiotiques prophylactiques: A randomized controlled study. Journal of Medical Sciences, 24, 2-7.
[8]
Bensouda-Grimaldi, L., Jonville-Béra, A.-P., Beau-Salinas, F., Llabres, S. and Autret-Leca, E. (2005) Implanon®: Difficulties of Insertion and Withdrawal, Contraceptive Failures. Gynecology Obstetrics & Fertility, 33, 986-990.
https://doi.org/10.1016/j.gyobfe.2005.10.016
[9]
Sivin, I., et al. (1997) Concentrations de lévonorgestrel pendant l’utilisation d’implants à tige de lévonorgestrel (LNG ROD). Contraception, 55, 81-85.
https://doi.org/10.1016/S0010-7824(96)00276-4
[10]
Jhpiego (2015) Providing Learning Resources on Contraceptive Implants. Baltimore (MD).
[11]
Blumenthal, P.D., et al. (1997) Training for Norplant Implant Removal: Assessment of Learning Curves and Competency. Obstetrics and Gynecology, 89, 174-178.
https://doi.org/10.1016/S0029-7844(96)00484-X
[12]
Organisation Mondiale de la Santé (OMS) (1990) Implants sous-cutanés contraceptifs Norplant: Directives managériales et techniques. OMS, Genève.
[13]
Walling, M. (2005) How to Remove Impalpable Implanon® Implants. BMJ Sexual & Reproductive Health, 31, 320-321. https://doi.org/10.1783/147118905774480770